Saturday 17 October 2026
Export MGTX’s income statement to Excel — free account
MeiraGTx Holdings PLC
MGTX Healthcare Biotechnology
MeiraGTx Holdings PLC’s revenue for fiscal 2025 (year ended December 2025) was $81.4 million, up 144.6% from fiscal 2024. In the quarter to June 2026, revenue grew 8,608.6%, EPS grew 466.7%, free cash flow grew 13.1% and total debt rose 28.6%, each against the same quarter a year earlier.
9.28
0.61
−6.17%
Follow MGTX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 72.22% | 963.07% | (368.19%) | (611.42%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 5 | 4 | |
| 26.54% | (51.44%) | (44.42%) | (69.00%) | ||
ROIC |
66.60% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
30.31% | (532.23%) | (152.94%) | 1,520.40% | |
Average Days of Receivables |
40.64 | 82.19 | 82.00 | 157.23 | |
Free Cash Flow per Share |
0.11 | 0.05 | (0.62) | (1.49) | |
Free Cash Flow |
10.12 | 4.28 | (50.06) | (120.50) | |
Capital Expenditures |
(3.57) | (3.99) | (3.70) | (4.24) | |
| Other line items | |||||
Cash ROIC |
2.21% | 6.78% | (45.53%) | 849.50% | |
Accounts Receivable Turnover |
15.57 | 6.96 | 5.82 | 2.71 | |
Accounts Payable Turnover |
0.44 | 0.20 | 0.29 | 0.63 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
522.49 | 1,659.89 | 758.64 | 486.06 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.03) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
38.53% | 161.52% | 159.25% | 447.87% | |
Selling, General and Administrative Expense of Revenue |
13.12% | 65.78% | 64.99% | 191.06% | |
Share Based Compensation of Revenue |
4.78% | 26.17% | 27.16% | 82.51% | |
Interest Coverage |
14.75 | (8.76) | (8.69) | (13.06) | |
Operating CF/Net income |
0.17 | (0.07) | 0.41 | 0.69 | |
Depreciation/Fixed assets |
0.13 | 0.13 | 0.13 | 0.13 | |
Capex/Depreciation |
(0.26) | (0.29) | (0.27) | (0.31) | |
Revenue per Share |
4.35 | 0.98 | 1.01 | 0.34 | |
Operating CF per Share |
0.15 | 0.10 | (0.58) | (1.44) | |
Capex per Share |
(0.04) | (0.05) | (0.05) | (0.05) | |
Capex to Sales |
0.01 | 0.05 | 0.05 | 0.15 |
Columns are period end dates